InsiderClue
Insiders · Profile

GOOD JENNIFER L

President & CEO at Trevi Therapeutics · Director at RHYTHM PHARMACEUTICALS. Filing since 9 May 2019. CIK 0001229245

TRVI Trevi Therapeutics, Inc. President & CEO · 9 trades RYTM RHYTHM PHARMACEUTICALS, INC. Director · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TRVI Trevi Therapeutics, Inc.
21 Mar 2025
President & CEO
Sold at will
5,263
$34.62K
2.4%
RYTM RHYTHM PHARMACEUTICALS, INC.
17 Sep 2024
Director
Sold on a plan
31,751
$1.66M
91.4%
RYTM RHYTHM PHARMACEUTICALS, INC.
9 Sep 2024
Director
Sold on a plan
37,241
$1.88M
92.5%
TRVI Trevi Therapeutics, Inc.
9 Sep 2024
President & CEO
Sold at will
1,840
$5.59K
0.9%
TRVI Trevi Therapeutics, Inc.
6 Sep 2024
President & CEO
Sold at will
4,219
$12.78K
1.9%
TRVI Trevi Therapeutics, Inc.
5 Sep 2024
President & CEO
Sold at will
40,277
$125.31K
15.9%
TRVI Trevi Therapeutics, Inc.
4 Sep 2024
President & CEO
Sold at will
10,981
$33.21K
4.9%
TRVI Trevi Therapeutics, Inc.
3 Sep 2024
President & CEO
Sold at will
3,863
$11.68K
1.8%
RYTM RHYTHM PHARMACEUTICALS, INC.
26 Aug 2024
Director
Sold on a plan
14,508
$725.53K
82.9%
TRVI Trevi Therapeutics, Inc.
20 May 2024
President & CEO
Sold at will
25,037
$71.58K
10.5%
TRVI Trevi Therapeutics, Inc.
10 May 2024
President & CEO
Sold at will
4,578
$13.28K
2.1%
TRVI Trevi Therapeutics, Inc.
9 May 2019
See Remarks
Bought
11,250
$112.50K
5.8%
12 decisions on file.